|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Enzinger PC and Mayer RJ: Esophageal
cancer. N Engl J Med. 349:2241–2252. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu PC and Posner MC: The role of surgery
in the management of oesophageal cancer. Lancet Oncol. 4:481–488.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nichols RJ and Traktman P:
Characterization of three paralogous members of the mammalian
vaccinia related kinase family. J Biol Chem. 279:7934–7946. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nezu J, Oku A, Jones MH and Shimane M:
Identification of two novel human putative serine/threonine
kinases, VRK1 and VRK2, with structural similarity to vaccinia
virus B1R kinase. Genomics. 45:327–331. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Valbuena A, Sanz-García M, López-Sánchez
I, Vega FM and Lazo PA: Roles of VRK1 as a new player in the
control of biological processes required for cell division. Cell
Signal. 23:1267–1272. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Molitor TP and Traktman P: Molecular
genetic analysis of VRK1 in mammary epithelial cells: Depletion
slows proliferation in vitro and tumor growth and metastasis in
vivo. Oncogenesis. 2:e482013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Santos CR, Rodríguez-Pinilla M, Vega FM,
Rodríguez-Peralto JL, Blanco S, Sevilla A, Valbuena A, Hernández T,
van Wijnen AJ, Li F, et al: VRK1 signaling pathway in the context
of the proliferation phenotype in head and neck squamous cell
carcinoma. Mol Cancer Res. 4:177–185. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Vega FM, Gonzalo P, Gaspar ML and Lazo PA:
Expression of the VRK (vaccinia-related kinase) gene family of p53
regulators in murine hematopoietic development. FEBS Lett.
544:176–180. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Valbuena A, López-Sánchez I and Lazo PA:
Human VRK1 is an early response gene and its loss causes a block in
cell cycle progression. PLoS One. 3:e16422008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lee N, Kwon JH, Kim YB, Kim SH, Park SJ,
Xu W, Jung HY, Kim KT, Wang HJ and Choi KY: Vaccinia-related kinase
1 promotes hepatocellular carcinoma by controlling the levels of
cell cycle regulators associated with G1/S transition. Oncotarget.
6:30130–30148. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mon AM, MacKinnon AC Jr and Traktman P:
Overexpression of the VRK1 kinase, which is associated with breast
cancer, induces a mesenchymal to epithelial transition in mammary
epithelial cells. PLoS One. 13:e02033972018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim IJ, Quigley D, To MD, Pham P, Lin K,
Jo B, Jen KY, Raz D, Kim J, Mao JH, et al: Rewiring of human lung
cell lineage and mitotic networks in lung adenocarcinomas. Nat
Commun. 4:17012013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Margalit A, Brachner A, Gotzmann J,
Foisner R and Gruenbaum Y: Barrier-to-autointegration factor-a
BAFfling little protein. Trends Cell Biol. 17:202–208. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Margalit A, Neufeld E, Feinstein N, Wilson
KL, Podbilewicz B and Gruenbaum Y: Barrier to autointegration
factor blocks premature cell fusion and maintains adult muscle
integrity in C. elegans. J Cell Biol. 178:661–673. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gorjanacz M, Klerkx EP, Galy V, Santarella
R, López-Iglesias C, Askjaer P and Mattaj IW: Caenorhabditis
elegans BAF-1 and its kinase VRK-1 participate directly in
post-mitotic nuclear envelope assembly. EMBO J. 26:132–143. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Jamin A, Wicklund A and Wiebe MS: Cell-
and virus-mediated regulation of the barrier-to-autointegration
factor's phosphorylation state controls its DNA binding,
dimerization, subcellular localization, and antipox viral activity.
J Virol. 88:5342–5355. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bengtsson L and Wilson KL:
Barrier-to-autointegration factor phosphorylation on ser-4
regulates emerin binding to lamin A in vitro and emerin
localization in vivo. Mol Biol Cell. 17:1154–1163. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lancaster OM, Cullen CF and Ohkura H:
NHK-1 phosphorylates BAF to allow karyosome formation in the
drosophila oocyte nucleus. J Cell Biol. 179:817–824. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim W, Lyu HN, Kwon HS, Kim YS, Lee KH,
Kim DY, Chakraborty G, Choi KY, Yoon HS and Kim KT: Obtusilactone B
from machilus thunbergii targets barrier-to-autointegration factor
to treat cancer. Mol Pharmacol. 83:367–376. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nichols RJ, Wiebe MS and Traktman P: The
vaccinia-related kinases phosphorylate the N′ terminus of BAF,
regulating its interaction with DNA and its retention in the
nucleus. Mol Biol Cell. 17:2451–2464. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li J, Wang T, Pei L, Jing J, Hu W, Sun T
and Liu H: Expression of VRK1 and the downstream gene BANF1 in
esophageal cancer. Biomed Pharmacother. 89:1086–1091. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Martin KJ, Patrick DR, Bissell MJ and
Fournier MV: Prognostic breast cancer signature identified from 3D
culture model accurately predicts clinical outcome across
independent datasets. PLoS One. 3:e29942008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Salzano M, Vázquez-Cedeira M, Sanz-García
M, Valbuena A, Blanco S, Fernández IF and Lazo PA: Vaccinia-Related
kinase 1 (VRK1) confers resistance to DNA-damaging agents in human
breast cancer by affecting DNA damage response. Oncotarget.
5:1770–1778. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sanz-García M, Monsalve DM, Sevilla A and
Lazo PA: Vaccinia-Related kinase 1 (VRK1) is an upstream
nucleosomal kinase required for the assembly of 53BP1 foci in
response to ionizing radiation-induced DNA damage. J Biol Chem.
287:23757–23768. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
López-Sánchez I, Valbuena A,
Vázquez-Cedeira M, Khadake J, Sanz-García M, Carrillo-Jiménez A and
Lazo PA: VRK1 interacts with p53 forming a basal complex that is
activated by UV-induced DNA damage. FEBS Lett. 588:692–700. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Margalit A, Liu J, Fridkin A, Wilson KL
and Gruenbaum Y: A lamin-dependent pathway that regulates nuclear
organization, cell cycle progression and germ cell development.
Novartis Found Symp. 264:231–240. 2005.PubMed/NCBI
|
|
29
|
Qi R, Xu N, Wang G, Ren H, Li S, Lei J,
Lin Q, Wang L, Gu X, Zhang H, et al: The lamin-A/C-LAP2alpha-BAF1
protein complex regulates mitotic spindle assembly and positioning.
J Cell Sci. 128:2830–2841. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li J, Hu B, Fang L, Gao Y, Shi S, He H,
Liu X and Yuan C: Barrier-To-Autointegration factor 1: A novel
biomarker for gastric cancer. Oncol Lett. 16:6488–6494.
2018.PubMed/NCBI
|
|
31
|
Molitor TP and Traktman P: Depletion of
the protein kinase VRK1 disrupts nuclear envelope morphology and
leads to BAF retention on mitotic chromosomes. Mol Biol Cell.
25:891–903. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Reinhardt HC and Schumacher B: The p53
network: Cellular and systemic DNA damage responses in aging and
cancer. Trends Genet. 28:128–136. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Barcia R, López-Borges S, Vega FM and Lazo
PA: Kinetic properties of p53 phosphorylation by the human
vaccinia-related kinase 1. Arch Biochem Biophys. 399:1–5. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Waters K, Yang AZ and Reinke V:
Genome-Wide analysis of germ cell proliferation in C.elegans
identifies VRK-1 as a key regulator of CEP-1/p53. Dev Biol.
344:1011–1025. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Valbuena A, Vega FM, Blanco S and Lazo PA:
P53 downregulates its activating vaccinia-related kinase 1, forming
a new autoregulatory loop. Mol Cell Biol. 26:4782–4793. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lopez-Borges S and Lazo PA: The human
vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within
the mdm-2 binding site of the p53 tumour suppressor protein.
Oncogene. 19:3656–3664. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sevilla A, Santos CR, Barcia R, Vega FM
and Lazo PA: C-Jun phosphorylation by the human vaccinia-related
kinase 1 (VRK1) and its cooperation with the N-terminal kinase of
c-Jun (JNK). Oncogene. 23:8950–8958. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sevilla A, Santos CR, Vega FM and Lazo PA:
Human vaccinia-related kinase 1 (VRK1) activates the ATF2
transcriptional activity by novel phosphorylation on Thr-73 and
Ser-62 and cooperates with JNK. J Biol Chem. 279:27458–27465. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kang TH, Park DY, Kim W and Kim KT: VRK1
phosphorylates CREB and mediates CCND1 expression. J Cell Sci.
121:3035–3041. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Shin J, Chakraborty G, Bharatham N, Kang
C, Tochio N, Koshiba S, Kigawa T, Kim W, Kim KT and Yoon HS: NMR
solution structure of human vaccinia-related kinase 1 (VRK1)
reveals the C-terminal tail essential for its structural stability
and autocatalytic activity. J Biol Chem. 286:22131–22138. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kim W, Chakraborty G, Kim S, Shin J, Park
CH, Jeong MW, Bharatham N, Yoon HS and Kim KT: Macro histone H2A1.2
(macroH2A1) protein suppresses mitotic kinase VRK1 during
interphase. J Biol Chem. 287:5278–5289. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Cox JL, Mallanna SK, Ormsbee BD, Desler M,
Wiebe MS and Rizzino A: Banf1 is required to maintain the
self-renewal of both mouse and human embryonic stem cells. J Cell
Sci. 124:2654–2665. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Furukawa K, Sugiyama S, Osouda S, Goto H,
Inagaki M, Horigome T, Omata S, McConnell M, Fisher PA and Nishida
Y: Barrier-to-autointegration factor plays crucial roles in cell
cycle progression and nuclear organization in drosophila. J Cell
Sci. 116:3811–3823. 2003. View Article : Google Scholar : PubMed/NCBI
|
